A Couples-based Intervention for Transgender Women and Their Partners
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of Michigan
- Study ID
- NCT04067661
- Status
- Terminated
Conditions
- HIV Infections
- HIV Primary Infection
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- CHIP — BEHAVIORALThe couples-based HIV prevention intervention consists of four couples counseling sessions focused on relationship skills to decrease HIV risk behaviors.
- Control — BEHAVIORALEnhanced standard of care, which includes information and referrals on HIV risk and prevention.
Study Details
This project seeks to test the efficacy of a couples-based HIV prevention program in large-scale randomized controlled trial (RCT) to reduce HIV risk among transgender woman and their partners. This project involves enrolling a racially diverse sample of transgender women and their partners and randomizing 50 couples to either the couples-based HIV prevention intervention or an enhanced standard of care (SOC) control condition. Couples will be followed quarterly over 12-months. Analysis of study outcomes will utilize both individual- and dyadic-level data. The primary outcome is a composite measure of risk for HIV transmission which encompasses validated behavioral indicators of HIV risk as well as biomedical confirmation of viral suppression and PrEP adherence.
Key Dates
- Start date
- Nov 1, 2019
- Status verified
- Jul 2025
- Primary completion
- Apr 30, 2024
- Completion
- Apr 30, 2024
Study Design
- Enrollment
- 104 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: InterventionParticipants and their partners will complete four couples counseling sessions focused on developing and enhancing relationship skills to decrease HIV risk behaviors.
- Active Comparator: ControlParticipants and their partners will receive information and referrals on HIV risk and prevention strategies.
Primary Outcome Measure
Condomless Sex [ Time Frame: Changes in self-reported condomless anal or vaginal sex at 12-month follow-up ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94158 | - |
Find similar trials in San Francisco, CA
Related Studies
- SCOPE: Observational Study of the Consequences of the Protease Inhibitor EraRecruiting · University of California, San Francisco · San Francisco, California
- Imaging Immune Activation in HIV by PET-MRPHASE2 · Recruiting · CellSight Technologies, Inc. · San Francisco, California
- CAR-T Cells for HIV InfectionPHASE1/PHASE2 · Recruiting · Steven Deeks · Sacramento, California
- Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV PreventionRecruiting · Public Health Foundation Enterprises, Inc. · San Francisco, California